Combined Angioplasty and Femorofemoral Bypass in the Treatment of Unilateral Iliac Arterial Occlusive Disease.
- Author:
Seok Hyung KANG
1
;
Young Duk CHUN
;
Youn Ki MIN
;
Heon Kyun HA
;
Jae Yeong JEON
;
Nam Ryeol KIM
;
Tae Jin SONG
;
Jae Bok LEE
;
Suk In JUNG
;
Yun Hwan KIM
;
Sang Yong CHOI
;
Cheung Wung WHANG
Author Information
1. Department of Surgery, Korea University College of Medicine, Seoul, Korea. sijung@ns.kumc.or.kr
- Publication Type:Original Article
- Keywords:
Angioplasty;
Femorofemoral bypass;
Iliac artery;
Occlusion
- MeSH:
Academic Medical Centers;
Angioplasty*;
Arterial Occlusive Diseases*;
Constriction, Pathologic;
Humans;
Hypertension;
Iliac Artery;
Korea;
Myocardial Ischemia;
Pathology;
Pulmonary Disease, Chronic Obstructive;
Stents;
Tissue Donors
- From:Journal of the Korean Society for Vascular Surgery
2002;18(1):46-52
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this article is to analyze the results of combined agioplasity and femorofemoral bypass in patients with unilateral iliac arterial occlusive disease. METHOD: During the 11-year period from 1990 to 2000, 44 patients with iliac artery occlusion and a hemodynamically significant contralateral iliac artery stenosis were treated by using a combination of percutaneous transluminal angioplasity (PTA) and femorofemoral bypass (n=18) as well as aortobifemoral bypass (n=12) and iliofemoral bypass (n=14) at Korea university medical center. PTA was performed if the lesions in the donor iliac artery were less than 3 cm in length with no more than one well-localized lesion in either the common or external iliac artery, or both. Stent was deployed for suboptimal PTAs. The femorofemoral bypass was done within 3 to 5 days after PTA or stenting. RESULT: The mean age was 61.2 years. The Indications of femorofemoral bypass were hypertension, ischemic heart disease, chronic obstructive lung disease, old age (>75), cancer, and previous abdominal operation. The complication rate of the combination treatment was lower than that of the others. Primary patency rate at 1 and 3 years were 89%, 78% for aortobifemoral bypass, 83%, 66% for iliofemoral bypass, and 77%, 65% for femorofemoral bypass, respectively. CONCLUSION: The combination of PTA with or without stent deployment and femorofemoral bypass can be a useful option for treating iliac occlusion and contralateral iliac stenosis in patients with severe comorbid illness, advanced age, and intra-abdominal pathology. Angioplasity can allow more widespread use of femorofemoral bypass in these patients.
